Stay updated with breaking news from Merck Sharp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Two of six patients receiving NOX-A12 in combination with bevacizumab and radiotherapy exceeded 24-month survival since the start of therapy This survival compares favorably to the 5% survival...
A 5-year randomised, placebo-controlled trial of pembrolizumab found a 38% reduction in death vs placebo.
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The
In this article, we discuss the 11 hot growth stocks to buy now.
In this article, we discuss the 11 hot growth stocks to buy now. If you want to read about some more growth stocks that are active in the market, go directly to the 5 Hot Growth Stocks To Buy Right Now. As 2024 moves forward, the outlook for both the stock and bond markets undergoes […]